Literature DB >> 2468191

A biophysical approach to capillary permeability.

B A Zikria1, T C King, J Stanford, H P Freeman.   

Abstract

In this preliminary report, the capillary leakage that occurs after scald injury is considered a biophysical phenomenon and is treated by sealing the "pores," or endothelial gaps, in the capillary membranes with biodegradable macromolecules of the appropriate size and shape. We have measured albumin leakage from standardized scald burns in the rat jejunum with and without variously sized fractions of intravenous macromolecules of hydroxyethyl starch (HES) used as a sealing agent. The observed reduction of albumin leakage from injured capillaries was attributed to the sealing effect. The fraction HES (Fm) with molecular weights of 100,000 to 300,000 daltons performed significantly better (p less than 0.05) as a sealing agent when compared with HES (F1) fraction molecular weights of 300,000 to 3.4 million daltons, HES (Fs) molecular weight less than 50,000 daltons, and two control groups receiving the intravenous Ringer's lactate solution or serum albumin 5%. This capillary sealing phenomenon was shown to be independent of colloid osmotic pressure effect. It is believed to be related to the size and the shape of the noncharged macromolecules.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468191

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

1.  Hypertonic/hyperoncotic solution attenuate blood-brain barrier breakdown and brain pathology in whole body hyperthermia rats.

Authors:  Youtan Liu; Jing Tang; Jionxian Ye; Lifang Zhan; Shaonong Huang; Tingting Wang; Miaoning Gu
Journal:  Int J Clin Exp Med       Date:  2011-10-19

2.  A narrow range, medium molecular weight pentastarch reduces structural organ damage in a hyperdynamic porcine model of sepsis.

Authors:  A R Webb; R F Moss; D Tighe; M G Mythen; N al-Saady; A E Joseph; E D Bennett
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 3.  Volume replacement and microhemodynamic changes in polytrauma.

Authors:  Brigitte Vollmar; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2004-04-28       Impact factor: 3.445

Review 4.  Intravenous volume replacement: which fluid and why?

Authors:  L Huskisson
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

5.  Effects of different types of hydroxyethyl starch (HES) on microcirculation perfusion and tissue oxygenation in patients undergoing liver surgery.

Authors:  Yinghua Cui; Bo Sun; Changsong Wang; Shujuan Liu; Peng Li; Jinghui Shi; Enyou Li
Journal:  Int J Clin Exp Med       Date:  2014-03-15

6.  Plasma expanders stabilize human microvessels in microfluidic scaffolds.

Authors:  Alexander D Leung; Keith H K Wong; Joe Tien
Journal:  J Biomed Mater Res A       Date:  2012-04-04       Impact factor: 4.396

7.  Influence of low-molecular-weight hydroxyethyl starch on microvascular permeability in patients undergoing abdominal surgery: comparison with crystalloid.

Authors:  Yuko Ando; Yoshiaki Terao; Makoto Fukusaki; Kazunori Yamashita; Masafumi Takada; Takahiro Tanabe; Koji Sumikawa
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

8.  The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study.

Authors:  R E Collis; P W Collins; C N Gutteridge; A Kaul; A C Newland; D M Williams; A R Webb
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

Review 9.  Systematic analysis of hydroxyethyl starch (HES) reviews: proliferation of low-quality reviews overwhelms the results of well-performed meta-analyses.

Authors:  Christiane S Hartog; Helga Skupin; Charles Natanson; Junfeng Sun; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2012-07-13       Impact factor: 17.440

10.  The Beneficial Effect of HES on Vascular Permeability and Its Relationship With Endothelial Glycocalyx and Intercellular Junction After Hemorrhagic Shock.

Authors:  Hongliang Zhao; Yu Zhu; Jie Zhang; Yue Wu; Xinming Xiang; Zisen Zhang; Tao Li; Liangming Liu
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.